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Notch2 activation induced by Delta-like-1 (DL1)
drives development of splenic marginal zone (MZ)
B cells, an innate-like lineage that protects against
sepsis. DL1 interacts with Notch2 weakly, but it is
not known whether enhancement of DL1-induced
Notch2 activation by Fringe glycosyltransferases is
important for MZ B cell development. Furthermore,
DL1-expressing cells that promote MZ B cell devel-
opment have not been identified. We show that
Lunatic Fringe (Lfng) and Manic Fringe (Mfng) coop-
eratively enhanced the DL1-Notch2 interaction to
promote MZ B cell development. We also identified
radio-resistant red pulp endothelial cells in the
splenic MZ that express high amounts of DL1 and
promoted MZ B generation. Finally, MZ B cell pre-
cursor competition for DL1 homeostatically regu-
lated entry into the MZ B cell pool. Our study has
revealed that the Fringe-Notch2 interaction has
important functions in vivo and provides insights
into mechanisms regulating MZ B cell development.
INTRODUCTION
Marginal zone (MZ) B cells mediate rapid T cell-independent
antibody responses to blood-borne pathogens (Martin and Kear-
ney, 2002; Pillai et al., 2005). In contrast to the more abundant
follicular (Fo) B cells that mediate highly diverse T cell-dependent
B cell responses, the repertoire of MZ B cells is enriched for
B cell antigen receptors (BCR) that recognize microbial polysac-
charides in a T cell-independent fashion (Martin and Kearney,
2000, 2002). MZ B cells also express high amounts of germline-
encoded Toll-like receptors (Oliver et al., 1999) that recognize
pathogen-associated molecules such as lipopolysaccharide
and complement receptors (CD21), both key mediators of innate
immunity (Pasare and Medzhitov, 2005). Fo B cells recirculate,
whereas sessile MZ B cells are strategically localized within the
splenic MZ, at the interface of the white pulp (WP) lymphoid folli-
cles and red pulp (RP) cords. Blood released from splenic arte-
rioles into marginal sinuses (MS) percolates through the MZ254 Immunity 30, 254–263, February 20, 2009 ª2009 Elsevier Inc.before being collected by open-ended RP venules (Groom
et al., 1991; Mebius and Kraal, 2005; Schmidt et al., 1993).
Thus, the splenic vasculature is an open, rather than closed,
circulatory network that is uniquely adapted for filtration of sen-
escent red blood cells and microorganisms from the circulation.
In addition to specialized MZ B cells, the MZ contains a dense
array of dendritic cells (DCs), macrophages, and nonhemato-
poietic reticular fibroblasts that rapidly trap circulating soluble
and particulate antigens released from MS (Pillai et al., 2005).
However, there is currently little knowledge about how the MZ
microenvironment fosters MZ B cell development, nor how the
size of the MZ B cell pool is regulated.
Notch signaling has recently emerged as an essential regu-
lator of MZ B cell development. Notch receptors are type-I trans-
membrane proteins with large extracellular and intracellular
domains (Harper et al., 2003; Koch et al., 2003). Notch ligands
are members of the conserved Delta and Serrate (also known
as Jagged) families, based on homology to their Drosophila
prototypes. Interactions between Notch ligands and receptors
induce proteolysis to release a Notch intracellular domain (NIC)
fragment from its membrane tether (Lubman et al., 2004). NIC
then travels to the nucleus and interacts with the transcription
factor RBP-Jk to induce expression of Notch target genes. There
are four mammalian Notch receptors, three Delta-like ligands,
and two Serrate-like ligands. Whereas Notch1 is essential for
intrathymic T cell development, B lineage specification and
commitment in the bone marrow (BM) do not require Notch acti-
vation (Maillard et al., 2005). Moreover, Fo B cells develop in
a Notch-independent fashion (Tanigaki et al., 2002). In contrast,
no MZ B cells develop in mice conditionally lacking Notch2 or
Delta-like1 (Dll1), suggesting that DL1-Notch2 interactions are
essential for MZ B cell generation in the spleen (Hozumi et al.,
2004; Saito et al., 2003).
MZ B cells develop from newly formed IgMhiIgDloCD21lo
immature B cells, also known as Transitional-1 (T1) cells, after
they migrate from the bone marrow to the spleen. T1 cells die
rapidly or mature into Fo or MZ B cells via an intermediate Tran-
sitional-2 (T2) IgMhiIgDhi stage (Loder et al., 1999; Pillai et al.,
2005). MZ B cell precursors (MZPs) can be distinguished from
Fo precursors (FP) in the T2 compartment by their higher expres-
sion of innate receptors such as CD1d and CD21 (Pillai et al.,
2005; Srivastava et al., 2005). Both MZPs and MZ B cells are
absent in mice that conditionally lack Notch2 in CD19+ B cells
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induce T1 to differentiate into MZPs and then MZ B cells.
However, the DL1-expressing cell type(s) that drive this develop-
mental process have not been identified. Dll1 mRNA has been
detected in B cells, but B cell-specific deletion of Dll1 did not
affect MZ B cell generation (Hozumi et al., 2004), ruling out
‘‘lateral signaling’’ between B cells as an important mechanism.
Dll1mRNA has also been detected in splenic DCs (Kuroda et al.,
2003) and splenic stroma (Cheng et al., 2007), but it is not clear
whether hematopoeitic cells or nonhematopoietic stroma
present DL1 to MZPs in the spleen.
Both Notch2 and Dll1 display haploinsufficiency for MZ B cell
development (Hozumi et al., 2004; Saito et al., 2003), suggesting
that the DL1-Notch2 interactionmay be inherently weak. Indeed,
DL1 binding to Notch2 could not be detected with experimental
conditions that revealed robust binding of DL4 to Notch1
(Besseyrias et al., 2007). In Drosophila, weak Delta-Notch inter-
actions are often enhanced by Fringe, a Golgi-localized enzyme
that adds N-acetylglucosamine moieties to O-linked fucose on
EGF-like repeats of Notch (Haines and Irvine, 2003; Visan
et al., 2006b). This Notch modification enhances Delta-induced
activation and inhibits Serrate-induced activation during devel-
opment of several fly tissues (Haines and Irvine, 2003). There
are three vertebrate Fringe homologs: Lunatic (Lfng), Manic
(Mfng), and Radical Fringe. Genetic studies have implicated
Lfng as a critical regulator of Notch1 activation during vertebrate
somitogenesis (Dale et al., 2003; Morimoto et al., 2005), T cell
development (Koch et al., 2001; Tan et al., 2005; Visan et al.,
2006a), and T cell leukemogenesis (Uren et al., 2008). However,
mice lacking either Radical Fringe or Mfng do not display overt
abnormalities (Zhang et al., 2002; K.X. and S.E.E., unpublished
observations), and developmental functions have yet to be
defined for these Fringe proteins. It also remains unclear whether
different vertebrate Fringes have distinct or overlapping func-
tions in regulating Notch-dependent developmental processes.
Studies in cultured mammalian cells suggest that Lfng can
enhance DL-induced Notch1 signaling, similar to the potenti-
ating effect of Drosophila Fringe on Notch-Delta signaling (Hicks
et al., 2000;Moloney et al., 2000; Shimizu et al., 2001; Yang et al.,
2005). However, there have been conflicting reports on the ability
of Fringes to enhance Notch2 activation by DL ligands. In some
studies, Lfng overexpression potentiated DL1-induced Notch2
activation (Hicks et al., 2000) or DL1 binding to Notch2 (Bessey-
rias et al., 2007). In contrast, neither Mfng nor Lfng enhanced
DL1-induced Notch2 activation in another study (Shimizu et al.,
2001). These discordant results reveal limitations of approaches
that rely on transient overexpression of Notch and Fringe
proteins in cell lines. Although such approaches can sometimes
detect modest enhancements in DL-induced Notch reporter
gene expression, they provide little insight into the biological
functions of Notch-Fringe interactions in development. Impor-
tantly, therefore, the role of Lfng or Mfng in enhancing DL1-
induced Notch2 activation in vivo remains unresolved.
Here, we sought to identify the DL1-expressing splenic cells
that drive MZ B cell development and to determine how Lfng
and Mfng influence DL1-induced Notch2 activation during this
developmental process. Because previous studies have shown
that fewer MZ B cells develop in mice heterozygous for Notch2
or Dll1, we used haploinsufficiency as a genetic tool to identifyDL1-expressing cells that promote MZ B generation in the
spleen. Collectively, our studies suggest that Lfng and Mfng
cooperatively enhance MZP competition for limiting DL1 in RP
endothelial niches to homeostatically regulate the size of the
MZ B cell pool.
RESULTS
Expression ofNotch2,Hes1, and FringemRNA in Splenic
B Cell Subsets
We first sought to quantify Notch2, Lfng, and Mfng expression in
splenic B cell subsets. Although qRT-PCR studies have shown
that all splenic B cells subsets express Notch2 (Saito et al.,
2003), it is not clear whether Notch2 is homogeneously or hetero-
geneously expressed within each subset. We therefore analyzed
Notch2 expression in single cells from Notch2+/LacZ reporter
mice that were generated from embryonic stem cells harboring
b-geo (b-galactosidase [LacZ] fused with neomycin phospho-
transferase) inserted into the Notch2 locus. This insertion gener-
ates a null allele of Notch2, allowing LacZ to be expressed in its
place. We used FDG, a fluorogenic LacZ substrate, to provide
a sensitive flow cytometric method to quantify LacZ expression
in single splenic B cells from Notch2+/LacZ reporter mice. Notch2
mRNA is expressed by all newly formed and mature splenic B
cells (Saito et al., 2003). Interestingly, the FDG assay revealed
heterogeneous Notch2 expression levels in T1, FP, and Fo B
cells, whereas MZP and MZ B cells uniformly express higher
amounts of Notch2 (Figure 1A).
To determine whether any of the subsets display evidence of
recent Notch activation, we quantified expression of Hes1
mRNA, which encodes a transcriptional repressor that is a direct
Notch target gene (Maillard et al., 2005). Fo B cells expressed
low amounts of Hes1, whereas T1, MZP, and MZ B cells all
expressed 4- to 5-fold higher Hes1 mRNA (Figure 1B). Lfng
and Mfng mRNA were more uniformly expressed in all splenic
B cell subsets and the amounts detected did not vary more
than 2- to 3-fold between different populations (Figure 1C).
Because the half-life of Hes1 mRNA is very short, these data
suggest that DL1-Notch2 signaling begins in the T1 compart-
ment and continues to be active after MZ B cells have been
produced. However, we cannot rule out the possibility that other
Notch receptors regulate Hes1 expression in these cells.
Taken together, these results suggest that Lfng or Mfng (or
both) may modulate Notch2 activation by DL1 during MZ B cell
development.
DL1+ Radio-Resistant RP Vasculature Promotes
MZ B Cell Development
Because splenic DCs express Dll1 mRNA (Saito et al., 2003),
current paradigms suggest that these cells present DL1 to
MZPs to induce their development in MZ B cells (Lopes-
Carvalho and Kearney, 2004; Pillai et al., 2005). In order to test
this notion or to identify other DL1-expressing splenic cells that
drive MZ B cell development, we utilized mice harboring LacZ
knocked into the Dll1 locus, generating a null allele (Hrabe de
Angelis et al., 1997). By using the FDG assay, we did not observe
any LacZ+ hematopoietic cells in spleens fromDll1+/LacZ reporter
mice (not shown). Thus, DL1-LacZ expression in B cells and DCs
is below the threshold of detection for this technique. We nextImmunity 30, 254–263, February 20, 2009 ª2009 Elsevier Inc. 255
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Figure 1. Notch2, Hes1, Lfng, and Mfng Expression in Splenic B Cell Subsets
(A) Splenic B cells from 8-week-oldWT (top) andNotch2+/LacZ (bottom) mice were stained with fluorochrome-labeled anti-CD21, anti-IgM, and anti-CD23 prior to
loading with FDG and detection of b-galactosidase activity by flow cytometry. Subsets were defined based on IgM versus CD21 expression as shown in the left
panels. T1 cells were defined as IgMhiCD21loCD23lo, FP as IgMhiCD21intCD23int, and Fo were IgMint/loCD21intCD23hi. The IgMhiCD21hi subset was further sub-
divided intoMZP andMZB cells based on FSC and CD23 expression as shown in the middle panels. The percentages of each subset are indicated in the contour
plots. Histograms (right) depict LacZ expression in each splenic B cell subset from WT (red) versus Notch2+/LacZ (blue) mice. Numbers indicate the percent of
LacZ+ cells in Notch2+/LacZ mice above the WT background.
(B and C) Quantification ofHes1, Lfng, andMfngmRNA in sorted splenic B cell subsets. Poly(A)+ mRNA from individually sorted subsets was reverse-transcribed
into cDNA and the abundance ofHes1 (B), Lfng ([C], open bars), andMfng ([C], black bars) was determined by qRT-PCR. The number ofHes1, Lfng, orMfng cDNA
templates was divided by the number of Cd45 templates to yield normalized expression values. B cell subsets were sorted based on the following markers: T1,
B220+CD1dloCD23loCD21loIgMhi; Fo, B220+CD1dintCD23hiCD21int/loIgMint; MZP, B220+CD1dhiCD23hiCD21hiIgMhi; andMZ, B220+CD1dhiCD23int/loCD21hiIgMhi.
Bar graphs depict the mean normalized values (±SE) of triplicate measurements and are representative of at least two independent experiments (sorts) for each
subset.used X-GAL whole-mount staining to visualize LacZ expression
in spleens from Dll1+/LacZ mice in situ. We also performed
X-GAL whole-mount staining on spleens from Dll4 and Jagged1
(Jag1) LacZ reporter mice to determine whether these ligands
are expressed in the same or distinct regions of the spleen.
In Jag1+/LacZ mice, the branching network of splenic arteries
was strongly stained (Figure S1 available online). Splenic arteri-
oles were also strongly stained in Dll4+/LacZ mice, in addition to256 Immunity 30, 254–263, February 20, 2009 ª2009 Elsevier Inc.the marginal sinus and some RP vessels (Figure S2). In contrast,
in Dll1+/LacZ mice we observed predominant staining of RP
vasculature but no staining of MS or arterioles (Figure 2). Inter-
estingly, the density of X-GAL-stained vessels was particularly
high in RP areas immediately adjacent to WP follicles, as
evidenced by their dark blue outline when viewed at low magni-
fication (Figures 2A and 2B). Higher-magnification views re-
vealed strong LacZ staining within the cytoplasm of elongated
Immunity
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Figure 2. LacZ Expression in the Spleen of Dll1+/LacZ Reporter Mice
X-GAL whole-mount staining was performed on spleens from 10-week-old adult Dll1+/LacZ mice at steady state (A–C), or 8 weeks after lethal irradiation and
reconstitution with WT Lin BM progenitors (D) as described for Figure 3.
(A) Whole spleen viewed under dissecting scope.
(B–D) Paraffin sections counter-stained with neutral red are shown at 103 (B) and 403 (C and D). Note the X-GAL labeling of endothelial RP venules in the MZ
adjacent to the MS. WP areas are indicated. No splenic X-GAL staining was observed in WT littermates (data not shown).endothelial cells that interact closely with lymphocytes within the
vessel lumen as well as the exterior (Figure 2C). Thus, these
histochemical analyses reveal that DL1, DL4, and Jag1 are
expressed in partially overlapping vascular compartments of
the spleen. However, only DL1 was highly expressed within the
MZ. To confirm that DL1-expressing cells were nonhemato-
poietic, we generated BM chimeras in which lineage-depleted
(Lin) BM progenitors from Dll1+/+ wild-type (WT) donors were
used to reconstitute lethally irradiated Dll1+/LacZ hosts. Indeed,
strong LacZ expression was maintained in RP venules of the
MZ in WT/Dll1+/LacZ BM chimeras (Figure 2D), confirming that
these DL1-expressing cells are nonhematopoietic radio-resis-
tant vascular cells.
Althoughwe could not detect expression of DL1 in hematopoi-
etic cells from the spleen with the FDG flow cytometric assay, it
remained possible that hematopoietic cells expressing low
amounts of DL1 are required for MZ B cell development. To
test this possibility, we generated radiation BM chimeras to
determine whether DL1-expressing cells required to promote
MZ B cell generation are radio-resistant stromal cells (which
would include vasculature) or radio-sensitive hematopoietic
cells. In these studies, we capitalized on the fact that Dll1+/LacZ
and Notch2+/LacZ reporter mice both displayed haploinsuffi-
ciency for MZ B cell development (Figure S3), similar to thatreported for Notch2 and Dll1 conditional mutants (Hozumi
et al., 2004; Saito et al., 2003).
We generated WT/Dll1+/LacZ BM chimeras, as well as
reciprocal Dll1+/LacZ/WT chimeras and quantified donor-
derivedMZ and Fo B cells in spleens 2months later. Significantly
fewer MZ B cells were generated in WT/Dll1+/LacZ chimeras
than in Dll1+/LacZ/WT chimeras (p < 0.005; Figure 3A). Thus,
reducing Dll1 gene dosage in radio-resistant host stroma, but
not in donor-derived hematopoietic cells, compromised MZ B
cell generation. Reducing Notch2 gene dosage in donor-derived
hematopoietic cells similarly compromised MZ B cell generation
in WT hosts (Figure 3B), in line with previous observations (Saito
et al., 2003). Strikingly, this defect was greatly exacerbatedwhen
Notch2+/LacZ progenitors reconstituted lethally irradiated
Dll1+/LacZhosts (Figure 3B). These data reveal that Notch2 activa-
tion in MZPs requires interaction with DL1 on radio-resistant
stromal cells, rather than hematopoietic cells, to drive MZ B cell
generation.
Lfng or Mfng Deficiency Compromises MZ B Cell
Development in Competitive Chimeras
Data presented in Figure 3B reveal that very few MZ B cells can
develop from Notch2+/LacZ MZPs in Dll1+/LacZ hosts. The finding
that a 50% reduction in Notch2 and Dll1 gene dosage causesImmunity 30, 254–263, February 20, 2009 ª2009 Elsevier Inc. 257
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Notch2 interaction is inherently weak in vivo. This conclusion is
consistent with transfection studies showing that DL1 binding
to Notch2 was undetectable unless Lfng was expressed
together with Notch2 (Besseyrias et al., 2007). Because both
Lfng and Mfng were expressed in splenic B cell subsets
(Figure 1), we designed experiments to determine whether one
or both Fringes enhances DL1- and Notch2-dependent MZ B
cell development. We previously found that competitive
chimeras provide a powerful tool for elucidating Lfng functions
during Notch1-dependent phases of T cell development (Koch
et al., 2001; Tan et al., 2005; Visan et al., 2006a). In brief, single
(noncompetitive) chimeras via Lin BM or fetal liver (FL) donor
A
B
Figure 3. Dll1 Expressed by Radio-Resistant Spleen Cells Promotes
Notch2-Dependent Development of MZ B Cells
(A) MZ B cell generation in WT/Dll1+/LacZ versus Dll1+/LacZ/WT chimeras.
8 weeks after chimeras were established, spleen cells were stained with
antibodies specific for CD45.1 or CD45.2 together with B220, CD23, and
CD21 to quantify Fo and MZ B cells derived from WT B6.CD45.2 or Dll1+/LacZ
B6.CD45.1;CD45.2 donors. Horizontal bars represent themean values derived
from each experimental set. Number of MZ B cells/spleen (mean ± SE):
2.13 106 ± 3.43 105 (WT/Dll1+/LacZ) and 4.33 106 ± 3.33 105 (Dll1+/LacZ/
WT). Number of Fo B cells/spleen (mean ± SE): 4.2 3 107 ± 4.5 3 106 (WT/
Dll1+/LacZ) and 3.2 3 107 ± 2.9 3 106 (Dll1+/LacZ/WT).
(B) Interaction between DL1 and Notch2 in MZ B cell generation. Splenocytes
were stained with similar antibody combinations as described in (A) to define
FoB cells andMZB cells 5months after chimeras had been established. These
symbols represent the different experimental sets: squares (WT B6.CD45.1/
WT B6.CD45.2), triangles (Notch2+/LacZ B6.CD45.2/WT B6.CD45.1), inver-
ted triangles (WT B6.CD45.1/Dll1+/LacZ CD45.1;CD45.2), and diamonds
(Notch2+/LacZB6.CD45.2/Dll1+/LacZCD45.1;CD45.2). Number of MZ B cells/
spleen (mean ± SE): 4.2 3 106 ± 6.8 3 105 (WT/WT), 5.9 3 105 ± 2.2 3 104
(Notch2+/LacZ/WT), 1.2 3 106 ± 9.6 3 104 (WT/Dll1+/LacZ), and 1.3 3 105 ±
1.73 104 (Notch2+/LacZ/Dll1+/LacZ). Statistically significant differences calcu-
lated with one-sided Student’s t tests are indicated.258 Immunity 30, 254–263, February 20, 2009 ª2009 Elsevier Inc.cells were generated as described for Figure 3. Competitive
(mixed) chimeras were generated by mixing Lin BM cells from
B6.CD45.2 Mfng/ mice with equal numbers of wild-type (WT)
competitor B6.CD45.1;CD45.2 Lin BM cells and injecting into
lethally irradiated B6.CD45.1 hosts. Control WT/WT chimeras
injected with equal mixtures of B6.CD45.2 Mfng+/+ (or Mfng+/)
and WT B6.CD45.1;CD45.2 Lin BM cells were also generated
and analyzed. Because of the late embryonic lethality of most
Lfng/ pups (Evrard et al., 1998; Zhang and Gridley, 1998),
we set up mixed chimeras with Lin FL donor cells. In brief,
Lin FL cells from Lfng/ or Lfng-expressing (Lfng+/ or Lfng+/+)
B6.CD45.2 littermates were mixed with equal numbers of Lin
BM cells from WT B6.CD45.1;CD45.2 mice as competitors.
Lfng+/ and Lfng+/+ progenitors behaved identically in initial
experiments, and FL from both genotypes was pooled together
for all subsequent experiments. The chimeras were analyzed
with the staining and gating scheme displayed in Figure S4.
Mfng deficiency caused a slight but statistically significant
(p < 0.05) reduction in MZ B cell generation in mixed chimeras,
but did not compromise MZ B cell generation in single chimeras
(Figure 4A). Lfng deficiency caused a more striking competitive
defect in MZ B cell generation than did Mfng deficiency
(Figure 4B), but once again did not affect MZ B cell generation
under noncompetitive conditions. These data suggest that
both Mfng and Lfng enhance MZP competition for splenic DL1.
Although Lfng deficiency also impaired T cell progenitor compe-
tition for thymic DL ligands during Notch1-dependent phases of
T cell development (Visan et al., 2006a), Mfng deficiency did not
(unpublished data). Thus, Lfng critically enhances both Notch1
and Notch2 activation during T cell and MZ B cell development,
respectively, whereas Mfng uniquely enhances Notch2 activa-
tion during MZ B cell development.
Lfng and Mfng Cooperatively Promote MZ B Cell
Development
To determine whether Lfng and Mfng cooperatively or redun-
dantly regulate MZ B cell development, we isolated Lin FL
donor cells from Lfng/Mfng/ mice and Lfng+/+
Mfng/ or Lfng+/Mfng/ littermates, and we evaluated MZ
B production from both genotypes of FL liver donors in single
and in mixed chimeras. As before, we pooled FL from Lfng+/+
Mfng/ and Lfng+/Mfng/ genotypes in all experiments.
To generate mixed chimeras, WT Lin BM cells from
B6.CD45.1;CD45.2 mice were mixed with B6.CD45.2 Lin FL
donor cells. Strikingly, Lfng/Mfng/ donors generated signif-
icantly fewer (p < 0.005) MZ B cells than do Lfng+/+Mfng/ and
Lfng+/Mfng/ donors even in noncompetitive chimeras
(Figure 4C). This defect was further enhanced in competitive
chimeras, in which MZ B cells from Lfng/Mfng/ donors
were barely detectable. We also separately enumerated the
CD23hi MZPs and CD23lo MZ B cells within the IgMhiCD21hi
subset from each chimera (Figure S5). This analysis showed
that CD23hi MZPs are more prominent among IgMhiCD21hi cells
from Lfng/Mfng/ donors, suggesting that they do not effi-
ciently transition into the CD23lo MZ B cell pool. However, the
absolute number of MZPswas also profoundly reduced, demon-
strating that Lfng and Mfng deficiency dramatically impair MZP
generation. These results demonstrate that Lfng and Mfng act
Immunity
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Figure 4. MZ B Cell Generation from Mfng,
Lfng, and LfngMfng Mutant Progenitors
in Single and Mixed Chimeras
(A) MZ B cell production from WT versus Mfng/
donors in single and mixed chimeras. Left: Single
chimeras were generated by injecting lethally irra-
diated B6.CD45.1 hosts with WT (B6.CD45.1;
CD45.2) or Mfng/ (B6.CD45.2) Lin BM cells.
Right: Mixed chimeras were generated by inject-
ing B6.CD45.1 hosts with equal mixtures of WT
B6.CD45.1;CD45.2 and B6.CD45.2 Lin BM cells.
In control mixed chimeras, B6.CD45.2 donors
were Mfng+/+ or Mfng+/, and in mutant mixed
chimeras, B6.CD45.2 donors were Mfng/.
(B and C) MZ B cell production from Lfng+/+ and
Lfng+/ versus Lfng/ (B) or Lfng+/+Mfng/ and
Lfng+/Mfng/ versus Lfng/Mfng/ (C)
donors in single and mixed chimeras. Single (left)
and mixed (right) chimeras were generated as
described in (A), except that Lin FL B6.CD45.2
donor cells were used. After 2–5 months, numbers
of donor-derived MZP and MZ B cells in each
chimera were determined by staining splenocytes
as shown in Figure S4. For simplicity, we have
graphed the number of IgMhiCD21hi subset (which
includes CD23hi MZPs and CD23lo MZ B cells) in
each chimera. Horizontal lines represent the
mean values from each experimental set. Number
of MZP+MZ B cells/spleen (mean ± SE) in Mfng
single chimeras: 4.73 106 ± 9.03 105 (WT) versus
4.3 3 106 ± 2.3 3 105 (Mfng/); Mfng mixed
chimeras: 2.9 3 106 ± 3.7 3 105 (WT) versus
1.9 3 106 ± 2.6 3 105 (Mfng/); Lfng single
chimeras: 3.7 3 106 ± 2.5 3 105 (Lfng+/+ and
Lfng+/) versus 4.6 3 106 ± 8.4 3 105 (Lfng/);
Lfng mixed chimeras: 3.8 3 106 ± 2.1 3 105
(Lfng+/+ and Lfng+/) versus 1.9 3 106 ± 3.7 3
105 (Lfng/); Lfng/Mfng/ single chimeras:
3.9 3 106 ± 5.3 3 105 (Lfng+/+Mfng/ and
Lfng+/Mfng/) versus 2.2 3 106 ± 2.3 3 105
(Lfng/Mfng/); Lfng/Mfng/ mixed
chimeras: 1.8 3 106 ± 2.5 3 105 (Lfng+/+Mfng/
and Lfng+/Mfng/) versus 5.7 3 105 ± 1.0 3
105 (Lfng/Mfng/). Statistically significant
differences calculated with one-sided Student’s
t test are indicated. Similar results were obtained
in three independent experiments for single
chimeras and two independent experiments for
mixed chimeras.cooperatively to regulate DL1-induced Notch2 activation during
MZ B cell development.
Given that Mfng is highly expressed in BM HSCs (data not
shown), it was important to determine how loss of one or both
Fringes affected reconstitution of other hematopoietic compart-
ments. Although mixed chimeras were established with equal
numbers of FL and BM donor cells, WT FL strikingly outcom-
peted WT BM to reconstitute the BM compartment in all mixed
chimeras (not shown), as expected from previous reports (Rebel
et al., 1996; Visan et al., 2006a). We observed a similarly strong
bias in favor of Lfng/Mfng/ or Lfng+/+Mfng/ and Lfng+/
Mfng/ FL donor cells, since the myeloid (not shown), pre-B,
and Fo B cell compartments were comprised of 76%–84% FL-
derived cells (Figure 5). FL progeny also comprised 80%–90%
of the immature (B220hi IgM+) B cell compartment in the BM(data not shown). Despite this striking predominance of FL
progeny in BM, only 43% of splenic MZ B cells were derived
from Lfng+/+Mfng/ and Lfng+/Mfng/ FL, and only 25%
came from Lfng/Mfng/ FL in the other group of mixed
chimeras (Figure 5). These data reveal that loss of Mfng or
both Fringes does not compromise development ofmyeloid cells
or immature B cells in the BM, but selectively impairs MZ B cell
generation in the spleen. Collectively, our data suggest that both
Mfng and Lfng act cooperatively to enhance MZP competition
for limiting DL1.
To determine whether Fringe expression in MZPs enhances
recognition of DL1 on radio-resistant splenic stroma, we
measured MZ B cell generation from Lfng/ FL progenitors in
competition with WT BM progenitors in lethally irradiated WT
versus Dll1+/LacZ hosts. As before (Figure 3B), we found thatImmunity 30, 254–263, February 20, 2009 ª2009 Elsevier Inc. 259
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Impairs Reconstitution of MZP and MZ B
Cells without Affecting Pre-B and Fo B Cell
Reconstitution
Donor chimerism inmixed FL chimeras established
in Figure 4C were assessed by flow cytometry for
BM pre-B cells, splenic Fo B cells, and MZP+MZ
B cells. BM samples from each host were stained
with biotinylated anti-B220, anti-IgM, anti-CD45.1,
and anti-CD45.2 to quantify pre-B cells (B220+
IgM) from each donor. Splenic samples were
stained as described in Figure 4 to quantify Fo B
cells and MZP+MZ B cells derived from the FL
versus BM donor in each chimera. The percent
contributionofLfng+/+Mfng/ andLfng+/Mfng/
(left; squares) versus Lfng/Mfng/ FL donors
(right; squares) relative to WT BM progeny (trian-
gles) in each chimera is plotted. Data shown were
pooled from two independent experiments. The
mean percentages ± SE of FL and WT BM in the
pre-B, FoB, andMZPandMZBcell compartments
are indicated in the table directly below the plots.
Asterisk: The differential contributions of the FL
donors to the pre-B versus MZP-MZ B and Fo B
versus MZ B pools were significant (p < 0.0001)
according to the one-sided Student’s t test.Lfng/ FL progenitors made low numbers of MZ B cells when
competing with WT progenitors in WT hosts. However, the
competitive fitness of Lfng/ progenitors was decreased further
when they developed in Dll1+/LacZ hosts (Figure 6). These data
formally demonstrate that Lfng, Notch2, and DL1 interact genet-
ically to enhance MZ B cell development in vivo.
DISCUSSION
DL1-Notch2 interaction is essential for generating splenic MZ B
cells (Hozumi et al., 2004; Saito et al., 2003). Here we demon-
strate that DL1 is highly expressed by radio-resistant endothelial
cells in the MZ and RP and that Notch2-expressing MZPs
interact with DL1-expressing radio-resistant splenic stroma
(rather than DL1-expressing hematopoietic cells) to generate
MZ B cells. Our data suggest that this interaction is inherently
weak in vivo. Although the ability of Lfng and Mfng to enhance
Figure 6. Interaction between Dll1 and Lfng in MZ B Cell Generation
Lin FL cells from B6.CD45.2 Lfng/mice were mixed withWT BM and trans-
ferred into lethally irradiated WT or Dll1+/LacZ B6.CD45.1;CD45.2 hosts as
described for Figure 4B. Numbers of donor-derived MZP+MZ B cells were
determined 2 months later by flow cytometry. Number of Lfng/-derived
MZP+MZB cells/spleen (mean ± SE): 1.5 3 106 ± 1.3 3 105 (Dll1+/+ hosts),
and 4.93 105 ± 7.53 104 (Dll1+/LacZ hosts). Statistically significant differences
calculated with one-sided Student’s t tests are indicated.260 Immunity 30, 254–263, February 20, 2009 ª2009 Elsevier Inc.DL1-induced Notch2 activation has not been consistently seen
in vitro, we report here that both Fringes enhance DL1-induced
Notch2 activation in MZPs. This study demonstrates a biological
function for Mfng in vivo and shows that Lfng and Mfng enhance
DL-induced Notch2 activation during MZ B cell development.
Finally, our findings suggest that RP vasculature provides
a microenvironmental niche in which MZPs compete for limiting
DL1, homeostatically regulating the size of the MZ B cell pool.
Thus, we have identified important biological functions for
Fringe-Notch2 interaction in vivo and provide new insights into
mechanisms regulating MZ B cell development.
The nature and splenic localization of DL1-expressing cells
that drive MZ B cell development was previously unknown.
DL1 mRNA expression has been detected by RT-PCR in splenic
B cells (Hozumi et al., 2004), DCs (Saito et al., 2003), and stroma
(Cheng et al., 2007). A recent study reported strong immunos-
taining for DL1 and Jag1 in the MZ, but the cell types were not
identified (Santos et al., 2007). In contrast, we found that
Jag1-LacZ expression was restricted to splenic arteries and
arterioles that branch into the WP, whereas DL1-LacZ expres-
sion was most prominent in RP venules within the MZ. These
discordant results may reflect nonspecific staining with poly-
clonal antisera raised against DL1 and Jag1 (Lehar et al., 2005)
and/or differences in sensitivity of antibody versus LacZ detec-
tion techniques. Although DL4 was not highly expressed on
MZ vessels, it was strongly expressed in MS and scattered
vessels deep in the RP. Thus, newly formed T1 B cells released
from splenic arterioles would first contact DL4 inMSbefore inter-
acting with DL1 on MZ venules. However, no MZ B cells develop
in conditionally DL1-deficient mice (Hozumi et al., 2004), sug-
gesting that DL4 cannot activate Notch2 in MZPs. Nonetheless,
Lfng can enhance Notch2 binding to both DL1 and DL4 (Bessey-
rias et al., 2007). Thus, the preferential ability of DL1 to promote
Notch2-dependent MZ B cell development likely reflects
concentrated expression of DL1 in the MZ.
Immunity
Role of Fringe in Marginal Zone B Cell DevelopmentExpression of Notch ligands in splenic arteries was expected,
given that Notch signaling plays critical roles in arteriovenous
specification and vasculogenesis during embryonic develop-
ment (Gridley, 2007). However, expression of Notch receptors
and ligands is generally restricted to arteries (Villa et al., 2001).
We did not see DL1-LacZ expression in blood or lymphatic
vessels of lymph node, liver, or BM (unpublished observations),
suggesting that high DL1 expression is unique to the spleen.
Another group recently reported that DL1 expression on nonhe-
matopoietic cells is critical for MZ B cell development, though
the cell type(s) were not identified (Sheng et al., 2008). Vascular
endothelium is thought to provide a source of Notch-activating
ligands to nonvascular progenitor cells during liver development
(McCright et al., 2002). Furthermore, endothelial cells promote
Notch activation in neural stem cells and have thus been impli-
cated as a critical component of the neural stem cell niche
(Shen et al., 2004). We suggest that splenic RP DL1-expressing
endothelium provides a specialized niche that promotes Notch2
activation in T1s and MZPs after their release from the blood
stream, inducing some to adopt a MZ B cell fate.
We observed high expression of Hes1, a direct Notch target,
in T1, MZP, and MZ B cells, suggesting that they may have
recently been signaled by DL1 in the MZ. Conversely, Fo B cells
expressed low Hes1 mRNA, consistent with their predominant
localization within WP follicles where we could not detect
DL1-LacZ expression. The relatively high expression of Hes1 in
MZBcells suggests that DL1-inducedNotch2 activation persists
even after MZ B cells have been generated. Indeed, Notch2
signaling (enhanced by Lfng andMfng) may regulate the lifespan
ofmatureMZBcells, which are thought to be long-lived (Hao and
Rajewsky, 2001), in addition to their generation. However, MZ B
cells fail to remain localized to the MZ in sphingosine 1-phos-
phate receptor-deficient mice (Cinamon et al., 2004), suggesting
that persistent DL1-Notch2 interactionswithin theMZmaynot be
required to maintain MZ B cell identity or survival.
Our data strongly suggest that the DL1-Notch2 interaction is
inherently weak in vivo, because we observed a profound defect
in MZ B cell development when Notch2+/LacZ or Lfng/ progen-
itors developed in Dll1+/LacZ hosts. Neither Fringe was essential
to promote DL1-induced Notch2 activation during MZ B cell
development, as shown by the fact that MZPs lacking either
Lfng or Mfng generated normal numbers of MZ B cells in single
chimeras. However, loss of both Fringes significantly (p <
0.005) compromised MZ B cell generation in single chimeras,
suggesting that Lfng and Mfng redundantly enhance DL1-
induced Notch2 activation. In addition, MZPs lacking both Lfng
andMfng showed amuchmore severe defect inMZB cell gener-
ation than did single mutants under competitive conditions, also
suggesting some degree of redundancy. Nonetheless, with the
more sensitive competitive repopulation strategy, we observed
partial defects in single mutants, revealing that Lfng cannot
completely compensate for the loss of Mfng (and vice versa)
under these conditions. Thus, Lfng and Mfng can also act coop-
eratively to enhance the inherently weak DL1-Notch2 interaction
to promote MZ B cell development. This cooperation could
reflect the ability of Lfng and Mfng to modify different regions
of the Notch2 extracellular domain (Shimizu et al., 2001) and/or
the need for a high degree of Notch2 glycosylation to enhance
DL1 binding.Multiple lines of evidence suggest that weak BCR signals
promote MZ B cell generation whereas strong BCR signals
promote Fo B cell generation at the expense of MZ B cells (Pillai
et al., 2005). The ability of BCR signal strength to influence the Fo
versus MZ B cell fate choice likely underlies the notable skewing
of the BCR repertoire within the MZ B cell pool toward clono-
types that recognize microbial polysaccharides. However, it is
not yet clear how BCR and Notch2 signals are integrated during
MZ B cell development. Lfng and Mfng enhance the strength of
Notch signaling via DL1 (unpublished data). Thus, Lfng/ or
Notch2+/ MZ B cells presumably received a weaker Notch2
signal than did their WT counterparts as they developed from
MZPs. It will thus be important in future studies to determine
whether the strength of Notch2 signaling influences skewing of
the BCR repertoire that is selected into the MZ B cell pool.
Lfng/Mfng/ hematopoietic stem cells showed a selective
defect in MZP and MZ B cell generation, as revealed by
comparing the sizes of the BMmyeloid, pre-B cell, and Fo versus
MZ B cell pools in mixed chimeras. These data reveal that Lfng
and/or Mfng-mediated Notch2 modification enhances precursor
competition for limiting DL1, and this competition homeostati-
cally regulates generation of MZPs as well as entry into the MZ
B cell pool. Competition for limiting space or resources has
been shown to be an important general mechanism for imposing
homeostatic controls on organ size (de la Cova et al., 2004;
Moreno and Basler, 2004). The size of the peripheral B cell
pool is homeostatically regulated by B cell activator factor (Can-
cro, 2004; Casola, 2007). However, loss of this signaling pathway
compromises generation and maintenance of both Fo and MZ B
cell compartments, whereas our studies show that the Fringe-
DL1-Notch2 axis selectively regulates entry into the MZ B cell
pool. Lfng-Notch1 interactions regulate T cell progenitor compe-
tition for access to DL4 in thymic niches to homeostatically regu-
late the size of the cortical thymocyte pool (Hozumi et al., 2008;
Koch et al., 2008; Visan et al., 2006a). Thus, interactions among
distinct Fringe, Notch, and DL family members homeostatically
regulate T and B cell progenitor competition for limiting niches
in different lymphoid organs.
EXPERIMENTAL PROCEDURES
Mice
All animal protocols were approved by the Hospital for Sick Children Animal
Care Committee. B6.SJL-Ptprca (B6.CD45.1) and C57BL/6NTac-Ptprcb
(B6.CD45.2) mice were purchased (Taconic) and bred in a specific path-
ogen-free facility (Max Bell Research Center, Toronto, ON, Canada). These
mice were also intercrossed to produce B6.CD45.1;CD45.2 mice for adoptive
transfer experiments. Lfng+/ mice were obtained and maintained as previ-
ously described (Visan et al., 2006a). B6.129-Dll1tm1GosJ (Dll1+/LacZ) mice
were purchased from Jackson Laboratory and backcrossed at least ten gener-
ations to B6.CD45.2 mice. For adoptive transfer experiments, Dll1+/LacZ mice
(CD45.2) were intercrossed with WT B6.CD45.1 to generate Dll1+/LacZ
expressing both CD45.1 and CD45.2. DL-4+/LacZ mice (Duarte et al., 2004)
were obtained from J. Rossant and backcrossed to FVB. Jag1+/LacZ and
Notch2+/LacZ mice were generated from embryonic stem cell lines (BayGe-
nomics, San Francisco, CA) harboring b-geo (fusion of b-galactosidase and
neomycin phosphotransferase) inserted within the Jag1 and Notch2 genes,
respectively. Jag1+/LacZ and Notch2+/LacZ progeny were backcrossed 3–5
times (Jag1+/LacZ) and >10 times (Notch2+/LacZ) to B6.CD45.2. Mfng+/ mice
were generated by targeted insertion of the b-geo fusion gene into the first
intron ofMfng in embryonic stem cells by standard techniques and then back-
crossed R8 generations to B6.CD45.2 before intercrossing to generateImmunity 30, 254–263, February 20, 2009 ª2009 Elsevier Inc. 261
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backcrossed R10 generations to B6.CD45.2 unless specified. Mouse geno-
types were determined by PCR amplification of tail DNA.
Flow Cytometry
Single-cell suspensions were stained with fluorochrome-conjugated anti-
bodies and secondary reagents and analyzed as previously described (Tan
et al., 2005; Visan et al., 2006a). Fluorescein di-b-D-galactopyranoside
(FDG, Molecular Probes), a fluorogenic substrate for b-galactosidase, was
used to detect expression of bacterial b-galactosidase (LacZ) in WT,
Notch2+/LacZ, and Dll1+/LacZ mice according to the manufacturer’s protocol.
Antibody staining for extracellular markers was performed prior to loading cells
with FDG. The antibodies used in this study were previously described (Visan
et al., 2006a) except for anti-CD21 (7G6), anti-CD23 (B3B4), anti-IgM (R6-60.2
or II/41), anti-IgD (11-26C.2A), anti-CD1d (1B1). Purified antibodies or anti-
body-fluorochrome conjugates as well as second-stage reagents were
purchased from BD Biosciences and eBiosciences or produced with standard
techniques. Sorting for T1 and for FP, Fo,MZP, andMZB cell subsetswas per-
formed on a MoFlo (DakoCytomation) equipped with Argon I-90 and Krypton
302c lasers emitting excitation wavelengths of 488 and 647 nm, respectively.
The purity of all sorted subsets was greater than 97%.
Adoptive Transfers and Chimeras
Single and mixed chimeras were established with lineage-depleted BM or FL
as previously described (Visan et al., 2006a). For chimeras established with
Lfng/ FL donors, timed Lfng+/+ 3 Lfng+/ matings were set up and FL was
obtained at embryonic day 13.5 to 15.5 (E13.5–15.5). Lfng/ fetuses were
phenotypically distinguished from Lfng+/+ or Lfng+/ fetuses by their fused
ribcages and truncated tails. To generate chimeras with Lfng/Mfng/ FL
donors, timed Lfng+/Mfng/ intercross matings were set up. E13.5–E15.5
Lfng+/+Mfng/ and Lfng+/Mfng/ fetuses were distinguished from Lfng/
Mfng/ fetuses by their fused ribcages and truncated tails.
Immunohistology
Spleens from B6.CD45.1 and Dll1+/LacZmice were embedded and snap frozen
in OCT (n-octyl b-D glucopyranoside, Sigma-Aldrich). OCT-embedded
spleens were sectioned into 8-mm-thick section with a Cryostat (Leica) and
fixed in ice-cold acetone. Sections were rehydrated in PBS buffer for 15 min
and blocked with 10% normal mouse serum and 10% normal goat serum
for 40 min. The sections were subsequently stained with biotinylated anti-
IgM (R6-60.2; BD Biosciences) and anti-IgD-FITC (11-26C.2A; BD Biosci-
ences) resuspended in PBS with 2% normal goat serum for 60 min. Biotin
was visualized by staining with avidin-Cy3 (Cedarlane). Immunofluorescence
was analyzed on a confocal microscope (Zeiss).
mRNA Isolation and Real-Time PCR
Poly(A)+ mRNA from sorted T1 and T2FP (B220+CD1dintCD23int/loCD21int/lo),
Fo B cells (B220+CD1dintCD23hiCD21int/lo), MZP B cells (B220+CD1dhiCD23hi
CD21hi), and MZ B cells (B220+CD1dhiCD23int/loCD21hi) were isolated with the
mMACS mRNA Isolation Kit (Miltenyi Biotech). Reverse transcription was per-
formed with SuperScript First-Strand Synthesis System for RT-PCR (Invitro-
gen). The abundance of cd45, Lfng, Mfng, and Hes-1 were determined with
the Taqman qRT-PCR Assay Kit (Applied Biosystems) on ABI Prism 7900HT
thermal cyclers together with amplification primers and dual-labeled probes
complementary to an internal sequence of the corresponding genes. Normal-
ized values for Lfng, Mfng, and Hes-1 expression were determined as previ-
ously described (Tan et al., 2005). Primer sequences and probes for cd45,
Lfng, and Hes-1 were previously published (Tan et al., 2005; Visan et al.,
2006a). Primers and probes for Mfng were as follows: forward, 50-CTG GCT
TTG AAG ATG GTG CC-30; reverse, 50-TCG ATG ATG TAG CCC ACA GTG-30;
and probe 50-CCA GCG GCT CCC ACT TTG TGG A-30.
X-Gal Staining
Spleens from 2- to 4-month-old mice were harvested and fixed 0.2% glutaral-
dehyde, 1.5% formaldehyde, 5 mM EGTA, and 2 mM MgCl2, dissolved in
NaPO4 buffered solution (pH 7.3) for 20–25 min at 4
C on a Nutator. Spleens
were further cut into smaller pieces (1–2 mm thickness) and fixed for another
20 min prior to washing 3 times for 5 min each in 2 mM MgCl2, 0.01% deoxy-262 Immunity 30, 254–263, February 20, 2009 ª2009 Elsevier Inc.cholate, and 0.02% nonylphenyl-polyethylene glycol dissolved in NaPO4-
buffered solution. Tissue fragments were then incubated in 1 mg/mL X-gal
(4-bromo-5-chloro-3-indoyl-b-D-galactopyrosanide) solution (0.02% nonyl-
phenyl-polyethylene glycol, 0.02% deoxycholate, 5 mM K4Fe(CN)6$3H2O,
5 mM K3Fe(CN)6, 2 mM MgCl2, dissolved in 100 mM Tris [pH 7.3]) overnight
at 37C on a Nutator. Stained tissues were washed in PBS and then paraffin
embedded, sectioned, and counterstained with Neutral Red (Mount Sinai
Hospital Pathology Laboratory Services, Toronto).
SUPPLEMENTAL DATA
Supplemental Data include five figures and can be found with this article online
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